Safety and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and hepatitis B or hepatitis C infection
Ana Pertejo-Fernández, Biagio Ricciuti, Sarah P. Hammond, Francisco M. Marty, Gonzalo Recondo, Deepa Rangachari, Daniel B. Costa, Mark M. Awad
Topics & Concepts
MedicineInternal medicineDiscontinuationImmunotherapyLung cancerHepatitis C virusHepatitis CAdverse effectPopulationImmunologyViral loadHepatitisViral hepatitisHepatitis B virusCancerOncologyVirusEnvironmental healthCancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus Studies